Literature DB >> 31738829

Trends and factors affecting the US adult hematology workforce: a mixed methods study.

Deva Sharma1, Natalie Wallace2, Erik A Levinsohn3, Ariela L Marshall4, Karen Kayoumi5, Johanna Madero5, Morgan Homer5, Robby Reynolds5, Janet Hafler6, Nikolai A Podoltsev2, Alfred Ian Lee2.   

Abstract

The current demand for adult hematologists in the United States is projected to exceed the existing supply. However, no national study has systematically evaluated factors affecting the adult hematology workforce. In collaboration with the American Society of Hematology (ASH), we performed a mixed methods study consisting of surveys from the annual ASH In-Service Exam for adult hematology/oncology fellows from 2010 to 2016 (8789 participants); interviews with graduating or recently graduated adult hematology/oncology fellows in a single training program (8 participants); and 3 separate focus groups for hematology/oncology fellowship program directors (12 participants), fellows (12 participants), and clinicians (10 participants) at the 2016 ASH annual meeting. In surveys, the majority of fellows favored careers combining hematology and oncology, with more fellows identifying oncology, rather than hematology, as their primary focus. In interviews with advanced-year fellows, mentorship emerged as the single most important career determinant, with mentorship opportunities arising serendipitously, and oncology faculty perceived as having greater availability for mentorship than hematology faculty. In focus group discussions, hematology, particularly benign hematology, was viewed as having poorer income potential, research funding, job availability, and job security than oncology. Focus group participants invariably agreed that the demand for clinical care in hematology, particularly benign hematology, exceeded the current workforce supply. Single-subspecialty fellowship training in hematology and the creation of new clinical care models were offered as potential solutions to these workforce problems. As a next step, ASH is conducting a national, longitudinal study of the adult hematology workforce to improve recruitment and retention in the field.
© 2019 by The American Society of Hematology.

Entities:  

Year:  2019        PMID: 31738829     DOI: 10.1182/bloodadvances.2019000307

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  4 in total

Review 1.  Systems-based hematology: highlighting successes and next steps.

Authors:  Jori E May; Patrick C Irelan; Kailee Boedeker; Emily Cahill; Steven Fein; David A Garcia; Lisa K Hicks; Janice Lawson; Ming Y Lim; Colleen T Morton; Anita Rajasekhar; Satish Shanbhag; Marc S Zumberg; Robert M Plovnick; Nathan T Connell
Journal:  Blood Adv       Date:  2020-09-22

2.  Putting the Heme Back in Heme-Onc: an Evaluation of the Redesigned Hematology Track within the Dana Farber/Mass General Brigham Hematology-Oncology Fellowship.

Authors:  Robert M Stern; Helen M Shields; Ann S LaCasce; Stephen R Pelletier; Nancy Berliner
Journal:  J Cancer Educ       Date:  2022-05-20       Impact factor: 2.037

3.  An evaluation of the content of hematology and medical oncology fellowship websites.

Authors:  Muhammad Zain Farooq; Muhammad Daniyal; Palvisha Qasim; Houria Jamshed; Shehzeen Fatima Memon; Yumna Salman; Bushra Zafar Sayeed; Maham Abbasi; Michael Jaglal
Journal:  Ann Med Surg (Lond)       Date:  2022-07-01

4.  Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma.

Authors:  Mary Slavcev; Allison Spinelli; Elisabeth Absalon; Tara Masterson; Christoph Heuck; Annette Lam; Erwin De Cock
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.